サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1176432

2型糖尿病治療薬：世界市場の展望

Type 2 Diabetes Treatment: Global Market Outlook
出版日: | 発行: BCC Research | ページ情報: 英文 66 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
2型糖尿病治療薬：世界市場の展望
出版日: 2022年12月20日
発行: BCC Research
ページ情報: 英文 66 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の2型糖尿病治療薬の市場を調査し、市場背景、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 市場の展望

  • 市場のスナップショット

第2章 エグゼクティブサマリー

第3章 市場概要

  • 2型糖尿病の概要
  • 市場促進要因
  • 市場の課題
  • COVID-19の影響

第4章 新たな動向と機会

  • 血糖コントロールを超えた患者の転帰
  • デジタルヘルスによる糖尿病技術
  • 経口抗糖尿病薬に向けたトレンドの拡大
  • 医療へのアクセシビリティとアフォーダビリティへの焦点の拡大

第5章 市場内訳：投与経路・治療タイプ別

  • 2型糖尿病治療薬市場：投与経路別
    • 市場規模・予測
  • 注射薬市場：タイプ別
    • インスリン療法
    • グルカゴン様ペプチド1療法
    • 市場規模・予測
  • 経口薬市場：薬物クラス別
    • ジペプチジルペプチダーゼ-4阻害剤
    • ナトリウム-グルコース共輸送体-2阻害剤
    • グルカゴン様ペプチド1受容体アゴニスト
    • その他
    • 市場規模・予測
  • 2型糖尿病治療薬市場：治療タイプ別
    • 市場規模・予測
  • インスリン療法市場：インスリンタイプ別
    • 市場規模・予測
  • 非インスリン療法市場：薬物タイプ別
    • 市場規模・予測

第6章 市場内訳：地域別

  • 2型糖尿病治療薬市場の規模：地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 競合情勢

  • 主要企業の市場シェア
  • 最近の主な展開
  • ブロックバスター糖尿病治療薬・治療の収益
  • パテントクリフ

第8章 企業プロファイル

  • ASTRAZENECA PLC
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JANSSEN PHARMACEUTICALS INC.（JOHNSON & JOHNSON）
  • MERCK & CO., INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI

第9章 プロジェクトの範囲・調査手法

図表

List of Tables

  • Summary Table : Global Market for Type 2 Diabetes Treatment, by Region, Through 2027
  • Table 1 : Global Diabetes Estimates and Projections, 2019-2045
  • Table 2 : Global Prevalence of Diabetes, by Type, Through 2040
  • Table 3 : Age-Adjusted Comparative Prevalence of Diabetes, by Region, 2010-2040
  • Table 4 : First-Time Generic Drug Approvals for Type 2 Diabetes, October 2022-2021
  • Table 5 : Global Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
  • Table 6 : Global Market for Injectable Therapies for Type 2 Diabetes, by Type, Through 2027
  • Table 7 : Medications in the DPP-4 Inhibitor Family
  • Table 8 : Medications in the SGLT2 Inhibitor Family
  • Table 9 : Oral GLP-1 Receptor Agonists
  • Table 10 : Global Market for Oral Medications for Type 2 Diabetes, by Drug Class, Through 2027
  • Table 11 : Global Market for Type 2 Diabetes Treatment, by Therapy Type, Through 2027
  • Table 12 : Insulin Types and Their Features
  • Table 13 : Leading Insulin Products and Their Types
  • Table 14 : Global Market for Insulin for Type 2 Diabetes Treatment, by Insulin Type, Through 2027
  • Table 15 : Global Market for Non-Insulin Therapies for Type 2 Diabetes, by Drug Type, Through 2027
  • Table 16 : Global Market for Type 2 Diabetes Treatment, by Region, Through 2027
  • Table 17 : North American Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
  • Table 18 : North American Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
  • Table 19 : North American Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
  • Table 20 : North American Market for Type 2 Diabetes Treatment, by Country, Through 2027
  • Table 21 : European Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
  • Table 22 : European Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
  • Table 23 : European Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
  • Table 24 : European Market for Type 2 Diabetes Treatment, by Country, Through 2027
  • Table 25 : Asia-Pacific Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
  • Table 26 : Asia-Pacific Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
  • Table 27 : Asia-Pacific Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
  • Table 28 : Asia-Pacific Market for Type 2 Diabetes Treatment, by Country, Through 2027
  • Table 29 : RoW Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
  • Table 30 : RoW Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
  • Table 31 : RoW Oral Medications Market for Type 2 Diabetes, by Drug Class, Through 2027
  • Table 32 : RoW Type 2 Diabetes Treatment, by Sub-Region, Through 2027
  • Table 33 : Global Market Shares of Type 2 Diabetes Therapies Manufacturers, 2021
  • Table 34 : Global Type 2 Diabetes Treatment Market, Selected Recent Key Developments, September 2019-August 2022
  • Table 35 : Global Sales of the Blockbuster Diabetes Drugs and Therapies, 2021
  • Table 36 : Blockbuster Diabetes Therapies, by Therapy Type, 2021
  • Table 37 : Global Evolution of the Top-Selling Diabetes Drug and Therapy Brands, 2016-2021
  • Table 38 : U.S. Patent Expiry Dates for the Blockbuster Diabetes Drugs, 2021
  • Table 39 : Astrazeneca: Product Portfolio for Type 2 Diabetes Treatment
  • Table 40 : Astrazeneca: Selected Key Developments, 2020-October 2022
  • Table 41 : Biocon: Product Portfolio for Type 2 Diabetes Treatment
  • Table 42 : Biocon: Selected Key Developments, 2020-October 2022
  • Table 43 : Boehringer Ingelheim: Products Portfolio for Type 2 Diabetes Treatment
  • Table 44 : Boehringer Ingelheim: Selected Key Developments, 2019-October 2022
  • Table 45 : Eli Lilly and Co.: Products Portfolio for Type 2 Diabetes Treatment
  • Table 46 : Eli Lilly and Co.: Selected Key Developments, 2020-November 2022
  • Table 47 : Janssen Pharmaceuticals: Products Portfolio for Type 2 Diabetes Treatment
  • Table 48 : Merck & Co. Inc.: Products Portfolio for Type 2 Diabetes Treatment
  • Table 49 : Merck & Co. Inc.: Selected Key Developments, 2020-October 2022
  • Table 50 : Novartis: Products Portfolio for Type 2 Diabetes Treatment
  • Table 51 : Novo Nordisk: Products Portfolio for Type 2 Diabetes Treatment
  • Table 52 : Novo Nordisk: Selected Key Developments, 2019-October 2022
  • Table 53 : Sanofi: Products Portfolio for Type 2 Diabetes Treatment
  • Table 54 : Sanofi: Selected Key Developments, 2020-November 2022

List of Figures

  • Summary Figure : Global Market Share of Type 2 Diabetes Treatment, by Region, 2021
  • Figure 1 : Type 2 Diabetes Facts
  • Figure 2 : Global Diabetes Incidence
  • Figure 3 : Risk of Developing Diabetes-Related Comorbidities
  • Figure 4 : Global Market Shares of Type 2 Diabetes Treatment, by Route of Administration, 2021
  • Figure 5 : Global Market Shares of Injectable Therapies for Type 2 Diabetes, by Type, 2021
  • Figure 6 : Global Market Shares of Oral Medications for Type 2 Diabetes, by Drug Class, 2021
  • Figure 7 : Global Market Shares of Type 2 Diabetes Treatment, by Therapy Type, 2021
  • Figure 8 : Global Market Shares of Insulin for Type 2 Diabetes Treatment, by Insulin Type, 2021
  • Figure 9 : Global Market Shares of Non-Insulin Therapies for Type 2 Diabetes, by Drug Type, 2021
  • Figure 10 : Global Type 2 Diabetes Treatment Market, by Region
  • Figure 11 : Global Market Share of Type 2 Diabetes Treatment, by Region, 2021
  • Figure 12 : Global Market Shares of Type 2 Diabetes Treatment, by Region, 2027
  • Figure 13 : Global Market Shares of Type 2 Diabetes Therapies Manufacturers, 2021
  • Figure 14 : Global Evolution of the Top-Selling Insulin Brands, 2016-2021
  • Figure 15 : Global Evolution of the Top-Selling Non-Insulin Diabetes Drug Brands, 2016-2021
目次
Product Code: HLC287A

Highlights:

The goal is to provide an up-to-date analysis of the global type 2 diabetes treatment market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of type 2 diabetes treatment. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Report Scope:

In this report, the market has been segmented based on route of administration, therapy type and region. The report provides an overview of the global type 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based on route of administration, therapy type and geography. Market values have been estimated based on the total revenue of type 2 diabetes therapies providers.

The report covers the market for type 2 diabetes treatment with regard to the therapy type across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. It estimates the global market for type 2 diabetes treatment in 2021, and then provides projections for the expected market size through 2027.

The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Report Includes:

  • A comprehensive overview of the global market for the treatment of type 2 diabetes
  • Analyses of the global and regional market trends, with historic revenue data from 2019 to 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Understanding of the current and future market potential for this innovation driven market, and areas of focus to forecast the market into various segments and sub-segments
  • Discussion of the industry growth driving factors and challenges that will shape the market for type 2 diabetes treatment as the basis for projecting demand in the next few years (2022-2027)
  • Estimation of the actual market size and revenue forecast for global type 2 diabetes treatment market, and corresponding market share analysis by therapy type, route of administration, end user, and region
  • Holistic review of the COVID-19 pandemic implications on the global market for treatment of type 2 diabetes
  • Review of the patent grants and patent applications on type 2 diabetes treatment solutions and related technologies
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues

Table of Contents

Chapter 1 Market Outlook

  • 1.1 Market Snapshot

Chapter 2 Executive Summary

Chapter 3 Market Overview

  • 3.1 Type 2 Diabetes Overview
    • 3.1.1 What is Type 2 Diabetes?
    • 3.1.2 Prevalence and Epidemiology of Type 2 Diabetes
    • 3.1.3 Diagnosing Type 2 Diabetes
    • 3.1.4 Treatment for Type 2 Diabetes
  • 3.2 Market Drivers
    • 3.2.1 Rising Prevalence of Diabetes
    • 3.2.2 Next Generation of Type 2 Diabetes Treatment
    • 3.2.3 High Unmet Need
    • 3.2.4 Premium Pricing
    • 3.2.5 Collaborations and Licensing Agreements
  • 3.3 Market Challenge
    • 3.3.1 Loss of Exclusivity, Genericization and Pricing Pressure
    • 3.3.2 Evolving Regulatory Scenario
  • 3.4 Impact of COVID-19

Chapter 4 Emerging Trends and Opportunities

  • 4.1 Patient Outcomes Beyond Glucose Control
  • 4.2 Diabetes Technology with Digital Health
  • 4.3 Growing Trend Toward Oral Antidiabetics
  • 4.4 Growing Focus on Accessibility and Affordability of Medicine

Chapter 5 Market Breakdown by Route of Administration and Therapy Type

  • 5.1 Type 2 Diabetes Treatment Market by Route of Administration
    • 5.1.1 Market Size and Forecast
  • 5.2 Injectable Therapies Market by Type
    • 5.2.1 Insulin Therapy
    • 5.2.2 Glucagon-Like Peptide 1 Therapy
    • 5.2.3 Market Size and Forecast
  • 5.3 Oral Medications Market by Drug Class
    • 5.3.1 Dipeptidyl Peptidase-4 Inhibitors
    • 5.3.2 Sodium-Glucose Cotransporter-2 Inhibitors
    • 5.3.3 Glucagon-Like Peptide 1 Receptor Agonists
    • 5.3.4 Other Oral Antidiabetic Medications
    • 5.3.5 Market Size and Forecast
  • 5.4 Type 2 Diabetes Treatment Market by Therapy Type
    • 5.4.1 Market Size and Forecast
  • 5.5 Insulin Therapy Market by Insulin Type
    • 5.5.1 Market Size and Forecast
  • 5.6 Non-Insulin Therapies Market by Drug Type
    • 5.6.1 Market Size and Forecast

Chapter 6 Market Breakdown by Region

  • 6.1 Type 2 Diabetes Treatment Market Size by Region
  • 6.2 North America
  • 6.3 Europe
  • 6.4 Asia-Pacific
  • 6.5 Rest of the World

Chapter 7 Competitive Landscape

  • 7.1 Global Market Shares of Leading Companies
  • 7.2 Recent Key Developments
  • 7.3 Blockbuster Diabetes Drug and Therapy Revenue
  • 7.4 Facing the Patent Cliff

Chapter 8 Company Profiles

  • ASTRAZENECA PLC
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JANSSEN PHARMACEUTICALS INC. (JOHNSON & JOHNSON)
  • MERCK & CO., INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI

Chapter 9 Project Scope and Methodology

  • 9.1 Scope of Report
  • 9.2 Methodology
  • 9.3 Analyst's Credentials
  • 9.4 BCC Custom Research
  • 9.5 Related BCC Research Reports